Differential Downregulation of β 1 ‐Adrenergic Receptor Signaling in the Heart
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Bing Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: VA Northern California Health Care System Mather CA USA. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-1, Down-Regulation, Signal Transduction, Ryanodine Receptor Calcium Release Channel. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NHLBI NIH HHS.
Abstract (Originalsprache)
Background Chronic sympathetic stimulation drives desensitization and downregulation of β1 adrenergic receptor (β 1 AR) in heart failure. We aim to explore the differential downregulation subcellular pools of β 1 AR signaling in the heart. Methods and Results We applied chronic infusion of isoproterenol to induced cardiomyopathy in male C57BL/6J mice. We applied confocal and proximity ligation assay to examine β 1 AR association with L‐type calcium channel, ryanodine receptor 2, and SERCA2a ((Sarco)endoplasmic reticulum calcium ATPase 2a) and Förster resonance energy transfer‐based biosensors to probe subcellular β 1 AR‐PKA (protein kinase A) signaling in ventricular myocytes. Chronic infusion of isoproterenol led to reduced β 1 AR protein levels, receptor association with L‐type calcium channel and ryanodine receptor 2 measured by proximity ligation (puncta/cell, 29.65 saline versus 14.17 isoproterenol, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VA Northern California Health Care System Mather CA USA.
- Department of Pharmacology University of California at Davis Davis CA USA.
- Department of Clinical Pathology, Faculty of Medicine Mansoura University Mansoura Egypt.
- Department of Pharmacology, School of Medicine Southern University of Science and Technology Shenzhen China.
- Department of Pharmaceutical Toxicology China Medical University Shenyang China.
ORCID-Profile: Bing Xu, Sherif Bahriz, Victoria R Salemme, Chaoqun Zhu, Yang K Xiang
Förderung
- BLRD VA
- NHLBI NIH HHS
Zitieren
APA
Xu, B., Bahriz, S., Salemme, V. R., Wang, Y., Zhu, C., Zhao, M., & Xiang, Y. K. (2024). Differential Downregulation of β 1 ‐Adrenergic Receptor Signaling in the Heart. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033733
Vancouver
Xu B, Bahriz S, Salemme VR, Wang Y, Zhu C, Zhao M, et al. Differential Downregulation of β 1 ‐Adrenergic Receptor Signaling in the Heart. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033733
BibTeX
@article{Xu2024,
author = {Xu, Bing and Bahriz, Sherif and Salemme, Victoria R and Wang, Ying and Zhu, Chaoqun and Zhao, Meimi and Xiang, Yang K},
title = {Differential Downregulation of β 1 ‐Adrenergic Receptor Signaling in the Heart},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033733}
}
EUVIMED